|
US10155038B2
(en)
|
2007-02-02 |
2018-12-18 |
Yale University |
Cells prepared by transient transfection and methods of use thereof
|
|
US9249423B2
(en)
|
2007-02-02 |
2016-02-02 |
Yale University |
Method of de-differentiating and re-differentiating somatic cells using RNA
|
|
US8859229B2
(en)
*
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
|
US8450112B2
(en)
*
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
PH12013501201A1
(en)
*
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
JP5572863B2
(ja)
|
2011-06-24 |
2014-08-20 |
国立大学法人九州大学 |
Ｎｋ細胞の増幅方法
|
|
JP5989016B2
(ja)
*
|
2011-06-24 |
2016-09-07 |
国立大学法人九州大学 |
Ｎｋ細胞の増幅方法
|
|
WO2013040557A2
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
WO2013063419A2
(en)
*
|
2011-10-28 |
2013-05-02 |
The Trustees Of The University Of Pennsylvania |
A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
US9359447B2
(en)
|
2012-03-23 |
2016-06-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
|
CA2945320A1
(en)
|
2014-04-10 |
2015-10-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Drug regulated transgene expression
|
|
WO2016095934A2
(en)
*
|
2014-12-14 |
2016-06-23 |
El Abd Hisham Mohamed Magdy |
A novel genetic device to engineer cell behavior
|
|
WO2016123578A1
(en)
|
2015-01-30 |
2016-08-04 |
The Regents Of The University Of California |
Protein delivery in primary hematopoietic cells
|
|
US12577289B2
(en)
|
2015-06-30 |
2026-03-17 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Surrogate co-receptors for t cells and methods of use
|
|
WO2017004252A1
(en)
|
2015-06-30 |
2017-01-05 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Redirected cells with mhc chimeric receptors and methods of use in immunotherapy
|
|
RU2766690C2
(ru)
|
2015-07-28 |
2022-03-15 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Модифицированные моноциты/макрофаги, экспрессирующие химерные антигенные рецепторы, и их применения
|
|
WO2017027291A1
(en)
|
2015-08-07 |
2017-02-16 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific car t-cells for solid tumor targeting
|
|
EP3708587B1
(en)
|
2015-11-27 |
2024-05-22 |
Cartherics Pty. Ltd. |
Genetically modified cells and uses thereof
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Ｃａｒ ｔ細胞療法のための方法および組成物
|
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
|
CN110291200B
(zh)
|
2016-12-12 |
2024-05-14 |
西雅图儿童医院（Dba西雅图儿童研究所） |
对哺乳动物细胞中转基因表达的药剂配体诱导具有增大的灵敏度的嵌合转录因子变异体
|
|
CN110612119B
(zh)
|
2017-02-07 |
2024-10-29 |
西雅图儿童医院（Dba西雅图儿童研究所） |
磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
|
|
JP7178355B2
(ja)
|
2017-02-28 |
2022-11-25 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための組成物および方法
|
|
WO2018195339A1
(en)
|
2017-04-19 |
2018-10-25 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
CA3067382A1
(en)
|
2017-06-15 |
2018-12-20 |
The Regents Of The University Of California |
Targeted non-viral dna insertions
|
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
MX2019015505A
(es)
|
2017-06-30 |
2020-07-28 |
Inscripta Inc |
Metodos, modulos, instrumentos y sistemas de procesamiento de celulas automatizados.
|
|
US20210017247A1
(en)
*
|
2017-07-03 |
2021-01-21 |
Torque Therapeutics, Inc. |
Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
|
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
|
EP3675876A4
(en)
*
|
2017-09-01 |
2021-06-02 |
GPB Scientific, Inc. |
METHOD FOR PRODUCING THERAPEUTICALLY ACTIVE CELLS USING MICROFLUIDICS
|
|
EP3687621A4
(en)
|
2017-09-30 |
2021-08-11 |
Inscripta, Inc. |
Flow through electroporation instrumentation
|
|
KR102503130B1
(ko)
|
2017-10-27 |
2023-02-24 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
내인성 t 세포 수용체의 표적화된 대체
|
|
WO2019090355A1
(en)
*
|
2017-11-06 |
2019-05-09 |
Children's National Medical Center |
Cells expressing antibodies and methods of treatment using the same
|
|
JP2021509903A
(ja)
*
|
2018-01-05 |
2021-04-08 |
マックスサイト インコーポレーティッド |
癌の長期ｃａｒ処置
|
|
JP7549303B2
(ja)
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
EP3749753B1
(en)
*
|
2018-02-09 |
2025-04-02 |
Immatics US, Inc. |
Methods for manufacturing t cells
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
CN112105382A
(zh)
|
2018-02-23 |
2020-12-18 |
恩多塞特公司 |
用于car t细胞疗法的顺序方法
|
|
WO2019190874A1
(en)
|
2018-03-29 |
2019-10-03 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
|
US10376889B1
(en)
|
2018-04-13 |
2019-08-13 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
|
US10508273B2
(en)
|
2018-04-24 |
2019-12-17 |
Inscripta, Inc. |
Methods for identifying selective binding pairs
|
|
AU2019292919A1
(en)
|
2018-06-30 |
2021-03-11 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
CN112823011A
(zh)
|
2018-07-09 |
2021-05-18 |
加利福尼亚大学董事会 |
基于t细胞的免疫疗法的基因靶标
|
|
KR20210045418A
(ko)
|
2018-08-14 |
2021-04-26 |
소티오, 엘엘씨 |
크렙스 사이클을 조정하는 트랜스 대사 분자와 조합된 키메라 항원 수용체 폴리펩타이드 및 이의 치료적 용도
|
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
|
US11965154B2
(en)
|
2018-08-30 |
2024-04-23 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
|
AU2019336229A1
(en)
*
|
2018-09-07 |
2021-03-18 |
Sotio, LLC |
Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
|
|
US12600776B2
(en)
*
|
2018-10-19 |
2026-04-14 |
Cartexell Inc. |
Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same
|
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
|
AU2019368215B2
(en)
|
2018-10-22 |
2023-05-18 |
Inscripta, Inc. |
Engineered enzymes
|
|
CN111349615B
(zh)
*
|
2018-12-24 |
2024-08-13 |
上海细胞治疗集团股份有限公司 |
制备过表达外源基因的细胞的方法
|
|
AU2020232691B2
(en)
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
CN113631713A
(zh)
|
2019-03-25 |
2021-11-09 |
因思科瑞普特公司 |
酵母中的同时多重基因组编辑
|
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
|
AU2020288623A1
(en)
|
2019-06-06 |
2022-01-06 |
Inscripta, Inc. |
Curing for recursive nucleic acid-guided cell editing
|
|
US10920189B2
(en)
|
2019-06-21 |
2021-02-16 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
|
US11203762B2
(en)
|
2019-11-19 |
2021-12-21 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
|
KR102776469B1
(ko)
|
2019-12-10 |
2025-03-05 |
인스크립타 인코포레이티드 |
신규 mad 뉴클레아제
|
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
EP4069851A4
(en)
|
2019-12-18 |
2023-11-22 |
Inscripta, Inc. |
Cascade/dcas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
|
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
|
AU2021213705A1
(en)
|
2020-01-27 |
2022-06-16 |
Inscripta, Inc. |
Electroporation modules and instrumentation
|
|
AU2021217003A1
(en)
|
2020-02-04 |
2022-09-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Anti-dinitrophenol chimeric antigen receptors
|
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
|
CN115867294A
(zh)
|
2020-06-04 |
2023-03-28 |
凯瑞斯马治疗公司 |
嵌合抗原受体的新型构建体
|
|
WO2022060749A1
(en)
|
2020-09-15 |
2022-03-24 |
Inscripta, Inc. |
Crispr editing to embed nucleic acid landing pads into genomes of live cells
|
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
|
AU2021415461A1
(en)
|
2021-01-04 |
2023-08-17 |
Inscripta, Inc. |
Mad nucleases
|
|
US20240376451A1
(en)
|
2021-01-07 |
2024-11-14 |
Inscripta, Inc. |
Mad nucleases
|
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
|
AU2022366987A1
(en)
|
2021-10-14 |
2024-05-16 |
Arsenal Biosciences, Inc. |
Immune cells having co-expressed shrnas and logic gate systems
|
|
EP4279085A1
(en)
|
2022-05-20 |
2023-11-22 |
Mnemo Therapeutics |
Compositions and methods for treating a refractory or relapsed cancer or a chronic infectious disease
|
|
KR20250068649A
(ko)
|
2022-09-13 |
2025-05-16 |
아스널 바이오사이언시스, 인크. |
공동 발현된 tgfbr shrna를 갖는 면역 세포
|
|
EP4587570A2
(en)
|
2022-09-16 |
2025-07-23 |
Arsenal Biosciences, Inc. |
Immune cells with combination gene perturbations
|
|
KR20250158048A
(ko)
|
2023-03-03 |
2025-11-05 |
아스널 바이오사이언시스, 인크. |
Psma 및 ca9을 표적으로 하는 시스템
|
|
PE20252678A1
(es)
|
2023-03-13 |
2025-11-24 |
Arsenal Biosciences Inc |
Activadores de vias sinteticas
|
|
CN121038806A
(zh)
|
2023-04-25 |
2025-11-28 |
阿森纳生物科学公司 |
用于转录调控的新颖受体
|
|
WO2024233494A2
(en)
*
|
2023-05-05 |
2024-11-14 |
Cellfe, Inc. |
Methods and systems for rapid engineering of resting cells
|
|
WO2024259299A1
(en)
|
2023-06-14 |
2024-12-19 |
The Broad Institute, Inc. |
Compositions and methods for identification of vhh antibodies that bind a target antigen
|
|
WO2024259305A1
(en)
|
2023-06-14 |
2024-12-19 |
The Broad Institute, Inc. |
Vhh polypeptides that bind to mesothelin, compositions and methods of use thereof
|
|
WO2025199346A1
(en)
|
2024-03-20 |
2025-09-25 |
Arsenal Biosciences, Inc. |
Antigen binding proteins that bind tmprss4 and methods of use thereof
|
|
WO2026055342A1
(en)
|
2024-09-04 |
2026-03-12 |
Arsenal Biosciences, Inc. |
Synthetic pathway activators
|
|
WO2026076388A1
(en)
|
2024-10-03 |
2026-04-09 |
The Broad Institute, Inc. |
Vhh polypeptides that bind to claudin-18, compositions and methods of use thereof
|